Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.20.2
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Totals 4,194,188 3,567,113 4,194,188 3,567,113
Options to Purchase Common Stock [Member]        
Totals 1,781,488 1,678,345 1,781,488 1,678,345
Restricted Stock Unvested [Member]        
Totals 421,253 421,253
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO and Merger Common Stock Purchase Warrants [Member]        
Totals 1,988,175 393,477 1,988,175 393,477
Series H, H-3, H-6, and Pre-merger AYRO Seed Preferred Stock [Member]        
Totals 3,272 1,495,291 3,272 1,495,291